✦ LIBER ✦

Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels

✍ Scribed by Frank M. Sacks; Jean-Lucien Rouleau; Lemuel A. Moye; Marc A. Pfeffer; J. Wayne Warnica; J. Malcolm O. Arnold; David T. Nash; Lisa E. Brown; Francois Sestier; John Rutherford; Barry R. Davis; C. Morton Hawkins; Eugene Braunwald; The CARE Investigators

Book ID: 113981757
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 370 KB
Volume: 75
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(99)80631-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid levels, adherence to medication, b

Lipid levels, adherence to medication, baseline characteristics in the cholesterol and recurrent events (CARE) study

✍ J.M.O. Arnold; B.R. Davis; D.T. Nash; W. Insul Jr.; S. Lewis; R.M. Kohn; S.P. Gl 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Pravastatin reduces total mortality in p

Pravastatin reduces total mortality in patients with coronary heart disease and average cholesterol levels: relationship of baseline cholesterol and treatment effects in the LIPID trial

✍ Simes, R.J.; Baker, J.; MacMahon, S.; Hague, W.; Colquhoun, D.; West, M.; Arulch 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Baseline blood pressure, low- and high-d

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

✍ Pierre Amarenco; Larry B. Goldstein; Alfred Callahan III; Henrik Sillesen; Micha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Rationale and design of a secondary prev

Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)

✍ Uri Goldbourt; Solomon Behar; Henrietta Reicher-Reiss; Jacob Agmon; Elieser Kapl 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 888 KB

Relation of Clinical Benefit of Raising

Relation of Clinical Benefit of Raising High-Density Lipoprotein Cholesterol to Serum Levels of Low-Density Lipoprotein Cholesterol in Patients With Coronary Heart Disease (from the Bezafibrate Infarction Prevention Trial)

✍ Ilan Goldenberg; Michal Benderly; Roy Sidi; Valentina Boyko; Alexander Tenenbaum 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 385 KB

Design, rationale, and baseline characte

Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)

✍ The PPP Project Investigators 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 849 KB